Multiple Myeloma

Multiple Myeloma
ISBN-10
1935281453
ISBN-13
9781935281450
Series
Multiple Myeloma
Category
Medical
Pages
240
Language
English
Published
2010-08-24
Publisher
Demos Medical Publishing

Description

Multiple Myeloma: The second issue of Emerging Cancer Therapeutics focuses on multiple myelomas also known as plasma cell myeloma, KahlerÌs Disease and myelomatosis. It is estimated that over 20,000 new cases are diagnosed each year with over 10,000 people dying from these malignancies. Multiple myelomas are highly treatable but rarely curable. Thus it is crucial for the practitioner to be up-to-date on the latest insights regarding their management. Management options and outcomes for individuals with multiple myelomas improved dramatically with the introduction of chemotherapy. Even further improvements in prognosis have occurred because of the introduction of newer therapies such as pulse corticosteroids, thalidomide, bortezomib, and autologous and allogeneic stem cell transplantation. With the increased number of therapeutic options to choose from, the clinician is better placed to offer effective therapy but at the same time is challenged to keep abreast of the rapidly changing treatment landscape and the newly emerging data that is shaping the treatment options today and in the future. Multiple Myeloma provides a comprehensive and in-depth review of this group of malignancies. This volume reviews the current literature, provides critical evaluations of the data and offers evidence-based recommendations. About the Series: Emerging Cancer Therapeutics is an invited review publication providing a through analysis of key clinical research related to cancer therapeutics, including a discussion and assessment of current evidence, current clinical best practice, and likely near future developments. There is an emphasis throughout on multidisciplinary approaches to the specialty, as well as on quality and outcomes analysis. Published three times a year Emerging Cancer Therapeutics provides authoritative, thorough assessments of advances in therapeutics in all major areas of oncology, both solid and hematologic malignancies, with a focus on advances in medical and biological therapies with emerging clinical impact and encompassing new technologies with implications for management such as molecular imaging. Features of Emerging Cancer Therapeutics include: Editorial board of nationally recognized experts across the spectrum of Cancer Therapeutics In-depth, up-to-date expert reviews and analysis of major new developments in all areas of Cancer Therapeutics Issues edited by an authority in specific subject area Focuses on major topics in Cancer Therapeutics with in-depth articles covering advances in clinical and translational research developments, as well as clinical applications and experience Emphasizes multidisciplinary approaches to research and practice

Other editions

Similar books

  • Multiple myeloma (MM)
    By Sics Editore

    Affects primarily middle-aged and elderly patients.Recognize complications that require prompt intervention.A symptomless patient is usually not treated, whereas a symptomatic patient is actively treated.

  • Treatment of Multiple Myeloma and Related Disorders
    By Robert A. Kyle, S. Vincent Rajkumar

    This book is aimed at the practitioner who is looking to put these advances into clinical context. It will serve as an up-to-date resource for treatment of myeloma and related disorders.

  • Understanding Multiple Myeloma
    By Cristina Gasparetto, Dharshan Sivaraj

    The only text to provide both the doctor’s and patient’s views, Understanding Multiple Myeloma gives you authoritative, practical answers to your questions about treatment options, post-treatment quality of life, sources of support, and ...

  • Multiple Myeloma and Related Disorders
    By Gosta Gahrton, Brian Durie, Diana Samson

    During the past decade there has been an enormous increase in knowledge of multiple myeloma and related disorders, reflected in the publication of more than 5000 articles on the subject in scientific journals.

  • Contemporary Management of Multiple Myeloma
    By Vij Ravi

    Ravi Vij. Contemporary Management of Multiple Myeloma Contemporary Management of Multiple Myeloma ravi Vij, MD Associate Professor,. Prelims.

  • Multiple Myeloma
    By Hartmut Goldschmidt, Thomas Moehler

    This book, written by internationally acknowledged experts, covers a wide range of topics relating to multiple myeloma, including history, epidemiology, pathophysiology, clinical features, staging, and prognostic systems.

  • Hematologic Malignancies: Multiple Myeloma and Related Plasma Cell Disorders
    By Morie A. Gertz, Philip R. Greipp

    This handbook provides up-to-date and comprehensive treatment of all plasma cell disorders, including both common and rare disorders. All disease aspects from pathogenesis to most recent therapy are covered.

  • Multiple Myeloma, An Issue of Hematology/Oncology Clinics,
    By Kenneth C. Anderson

    Vasir B, Borges V, Wu Z, et al. Fusion of dendritic cells with multiple myeloma cells results in maturation and enhanced antigen presentation. Br J Haematol 2005;129(5):687–700. Luptakova K, Rosenblatt J, Glotzbecker B, et al.

  • Multiple Myeloma: Translational and Emerging Therapies
    By Kenneth C. Anderson, M. Ghobrial Irene

    This exciting new text, edited by lauded authorities on the topic, stands as the only available reference to assemble, review, and synthesizes the latest studies on translational therapies and clearly explains the impact of molecu

  • Multiple Myeloma - A New Era of Treatment Strategies
    By Kenneth C. Anderson, Klaus Podar

    "Multiple Myeloma (MM), the second most common blood cancer in adults, is a clonal plasma cell malignancy within the bone marrow characterized by osteolytic bone lesions, renal disease, and immunodeficiency.